Enteral Feeding Devices Market - Global Outlook & Forecast 2024-2029

MARKET OVERVIEW

The global enteral feeding devices market size was valued at USD 3.46 billion in 2023 and is expected to reach USD 4.85 billion by 2029, growing at a CAGR of 5.77%. The market is growing at a steady pace, and this trend is likely to continue during the forecast period due to the increasing prevalence of various chronic diseases, rising elderly population, increasing incidence of preterm births, and growing incidences of malnutrition in pregnant women. The occurrence of malnutrition, dysphagia, and eating disorders increases with age; it is also highly prevalent in hospital settings. Further, malnutrition is particularly a challenging problem among the pediatric and women population in developing countries of APAC, Africa, and Latin America. Also, the U.S. is North America's first leading enteral feeding devices market. In 2023, the U.S. was the major revenue contributor in the global enteral feeding devices market. The demand for enteral feeding devices in the region is increasing due to the increasing age population of 65 years and above. Furthermore, the continuous focus of vendors on technological advances and improvements has led to the development of highly advanced enteral feeding devices to provide comfort to patients and quality care.

MARKET TRENDS & DRIVERS

High Demand for Tube Feeding Among Cancer Patients
The prevalence and incidence of cancer are increasing at a staggering rate globally. Among all diseases/ailments, the usage of enteral feeding is relatively high in cancer patients. As a result, the high prevalence of various cancers, especially gastric, head and neck/throat, and esophageal cancers, as well as the increased need for enteral nutrition among cancer patients, is contributing to the overall growth of the global enteral feeding devices market. According to WHO, globally, there were an estimated 20 million new cases of cancer and 10 million deaths. The cancer burden will increase by approximately 60% over the next two decades. The predicted global burden will increase to about 30 million new cases by 2040, with the greatest increase occurring in low-and middle-income countries. This high prevalence of various cancers across the world will drive enteral nutrition among cancer patients, which is contributing to the overall enteral feeding devices market.

High Demand for Home Enteral Feeding
Home enteral nutrition (HEN) is emerging as the fastest-growing segment compared to tube feeding in various healthcare settings. Globally, the healthcare market has witnessed a paradigm shift in the last decade, with an increasing preference for home healthcare services compared to hospital-based ones. HEN has always been recognized as a life-saving procedure for patients requiring long-term nutritional support to maintain appropriate nutrition levels. Over the past few years, HEN therapy has become a standard of care in adult patients who require a long-term alternative to oral and parenteral feeding. Moreover, the increase in the geriatric and chronic disease population worldwide has led to a growing demand for home enteral tube feeding (HETF). The use of HETF has become more common globally due to advancements in technology, the development of the PEG technique, and government policy of shifting healthcare provisions from costly acute hospitals to community settings. For instance, globally, favorable government initiatives in promoting safe and effective enteral nutrition among home healthcare patients are likely to fuel the market growth of HEN during the forecast period.

Increasing Patients with Malnutrition & Aging
Globally, the prevalence of malnutrition and dysphagia is increasing, especially in chronic disease patients and elderly people. The occurrence of malnutrition is high in patients with chronic illnesses like cancer, neurological disorders, heart failure, and Chronic Obstructive Pulmonary Disease (COPD) and increases with age and in hospital settings. Malnutrition is a common problem affecting around 40% of all hospitalized patients, increasing their morbidity and mortality. In Latin American hospitals, disease-related malnutrition was reported in around 50% of adult patients in countries like Argentina, Brazil, Chile, Mexico, Paraguay, Peru, Venezuela, and Uruguay. Alarmingly, high rates of disease-related malnutrition have been diagnosed in hospitalized patients of both emerging and industrialized nations over the past two decades despite remarkable advances in medical care. Nutrition through enteral tubes can be provided if a patient cannot take adequate nutritional supplements orally into the stomach or small bowel. Therefore, the increasing number of people with chronic conditions coupled with the rising elderly population is encouraging many clinicians worldwide to recommend enteral feeding as nutritional support to address dysphagia and malnutrition problems. As a result, the demand for enteral feeding pumps, tubes, and other accessories is increasing steadily, which, in turn, is driving the growth of the global enteral feeding devices market.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT
The global enteral feeding devices market by product is segmented as enteral feeding pumps, enteral feeding tubes, and accessories & consumables. In 2023, enteral feeding pumps accounted for the largest segmental share and dominated the global market. Enteral feeding pumps control the feeding duration and the amount of nutrition delivered to patients. As a result, they are considered the most important devices to carry out tube feeding. Enteral feeding pumps are in great demand for adult and pediatric tube feeding practices due to their essential functionality. As a result, many vendors focus on developing and manufacturing various enteral feeding pumps per end-user requirements. However, compared to feeding tubes and associated supplies required for enteral feeding, feeding pumps are manufactured in smaller quantities as they have a longer life and product life cycle.

INSIGHTS BY PATIENT GROUP
The adult patient group segment dominated the global enteral feeding devices market share in 2023. The dominance of this patient group segment is due to the increasing incidences and prevalence of various chronic and acute diseases that cause malnutrition, dysphagia, and swallowing problems. For instance, the rise in the prevalence of diseases like cancer, multiple sclerosis, stroke, dementia, chronic liver disease, COPD, and diabetes is projected to drive the demand for various enteral feeding devices that support patients with oral food intake issues. Also, the growing elderly population and changes in lifestyle patterns are significant factors driving the growth of this segment. Also, in adults who cannot swallow food by mouth after a prolonged illness, percutaneous endoscopic gastrostomy (PEG) tubes are used for feeding purposes. For instance, leading vendor Boston Scientific introduced the Safety Percutaneous Endoscopic Gastrostomy (PEG) Kit's Silicone dome-bolstered PEG tube in multiple sizes according to the patient's need.

INSIGHTS BY END-USER
The global enteral feeding devices market by end-users is segmented as hospitals, ambulatory care facilities, and home care settings. In 2023, the hospital segment held the most significant global market share, and the trend will likely continue during the forecast period. Healthcare professionals in hospitals use enteral feeding devices to quickly and accurately treat patients who cannot intake food through the oral route due to various severe and acute illnesses. The growing geriatric population and lifestyle changes are significant factors driving the market growth of the hospital segment. Also, the availability of skilled healthcare professionals with knowledge and expertise in enteral feeding attracts more patients to hospitals than other healthcare providers. Several other factors, such as improper diet and obesity, cause gastroenterological abnormalities, leading to a steady increase in the volume of various enteral feeding procedures, fueling the market growth of the hospital segment. For instance, in the U.S., approximately three million hospital admissions occur for GI diseases every year.

INSIGHTS BY APPLICATION
The global enteral feeding devices market by application is segmented as oncology, gastroenterology, neurology, cardiology & pulmonology, and others. The oncology segment accounted for the largest segmental market share in 2023. The growing prevalence and incidence of various types of cancer worldwide is a key driving factor for the growth of the oncology application segment. The most commonly diagnosed cancers among adults include lung cancer, followed by female breast cancer, prostate cancer, colorectal cancer, stomach cancer, and liver cancer. Further, the methods of nutrition support for cancer patients depend on the presence or absence of treatment plans, nutritional deficits, functioning gut, quality of life, and prognosis. A gastrostomy or jejunostomy tube is a feeding option if a patient has a functional gut but cannot meet their nutritional needs through oral intake.

GEOGRAPHICAL ANALYSIS

North America holds the most significant share of the global enteral feeding devices market, accounting for over 38% of the global revenue share in 2023. The enormous market share can be attributed to the rising preterm births, a growing number of chronic disease patients and elderly population, rising awareness regarding enteral nutrition and availability of various tube feeding options, and increasing healthcare expenditure in developed markets, with rapid improvisation of healthcare facilities. In addition to the increasing patient population, significant vendors such as Fresenius Kabi, Avanos Medical, Applied Medical Technology, Vygon Inc, Boston Scientific, B Braun Melsungen, and few other vendors have paced their production capacity to meet this high demand for enteral feeding devices within the region to boost the enteral feeding devices market.

During the forecast period, Europe is expected to witness a significant growth rate in the global enteral feeding devices market. The substantial share of enteral feeding devices in Europe is mainly due to the rising prevalence of various chronic diseases, with malnutrition and dysphagia as associated comorbidities. In addition, the relatively high awareness of tube feeding for treating malnutrition and dysphagia disorders in many patient groups contributes to the growth of the market in Europe. As a result, the number of patients seeking enteral nutrition through enteral feeding devices is increasing at a steady rate in this region. Furthermore, APAC is projected to witness the highest CAGR in the global enteral feeding devices market during the projected period. Japan is the major revenue contributor in this region due to a large pool of elderly population and relatively high uptake of tube feeding in various patient groups compared to other countries in the APAC region. Also, Thailand, Vietnam, Malaysia, and Indonesia are expected to witness a steady increase in demand for enteral feeding due to the growing healthcare expenditure and rising awareness for treating malnutrition and associated comorbidities with artificial nutrition support like tube feeding during the forecast period.

VENDOR LANDSCAPE

The global enteral feeding devices market is highly fragmented. Large corporations dominate the market. However, there are significant growth opportunities for new entrants. Though the market is dominated by major players, many investigational and small med-tech companies are coming into existence with innovative products and technologies. Further, Avanos Medical, Applied Medical Technology, B. Braun Melsungen, Boston Scientific, Cardinal Health, Cook Medical, Danone Nutricia, Fresenius Kabi, Nestlé, Vygon, and others are identified as the leading vendors in the global enteral feeding devices market. These companies have a wide geographical reach, diversified product portfolio, and a strong focus on innovation and research activities.

Applied Medical Technology is a leading global player and manufacturer of enteral feeding devices and surgical products. The company is dedicated to offering the highest quality and safety in patient care services. Through various relations and partnerships, the company aims to bridge the gap between the medical device market and the patient population, which enables it to offer the best industry services. Also, the company works closely with professional clinicians, caregivers, patients, and their family members to better understand enteral nutrition needs.